Drug Type Small molecule drug |
Synonyms CL-108 |
Action inhibitors, antagonists, agonists |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC8H9NO2 |
InChIKeyRZVAJINKPMORJF-UHFFFAOYSA-N |
CAS Registry103-90-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Pain | NDA/BLA | United States | 31 Mar 2016 | |
Nausea and vomiting | NDA/BLA | United States | 31 Mar 2016 | |
Osteoarthritis | Phase 3 | United States | 01 Oct 2014 | |
Drug-induced nausea and vomiting | Phase 3 | United States | 01 Sep 2014 | |
Nausea | Phase 3 | United States | 01 Sep 2014 | |
Vomiting | Phase 3 | United States | 01 Sep 2014 | |
Pain | Phase 1 | - | 01 Jun 2015 |